Warby Parker Inc.
NYQ: WRBYLive Quote
📈 ZcoreAI Score
Our AI model analyzes Warby Parker Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get WRBY Z-Score →About Warby Parker Inc.
Healthcare
Medical Instruments & Supplies
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
📊 Fundamental Analysis
Warby Parker Inc. demonstrates a profit margin of 0.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported 11.2% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 0.5%, which suggests room for improvement in capital utilization.
At a current price of $20.82, WRBY currently sits at the 41st percentile of its 52-week range (Range: $13.63 - $31.00).
💰 Valuation Insight
WRBY trades at a 8228.0% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
⚠️
Revenue Growth
Moderate
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$2.55B
Trailing P/E
2082.00
Forward P/E
30.83
Beta (5Y)
2.08
52W High
$31.00
52W Low
$13.63
Avg Volume
2.96M
Day High
Day Low